It’s Only Common Sense: If You’re Not Differentiated, You’re Dead
Alpha Insights, Performance by Design: The Future of PCB Manufacturing in the Midwest
Happy’s Tech Talk #43: Engineering Statistics Training With Free Software
Analog Devices Appoints Dr. Laurie H. Glimcher to Board of Directors
August 19, 2020 | Business WireEstimated reading time: 2 minutes
Analog Devices, Inc. announced the appointment of Dr. Laurie H. Glimcher, MD, to the Board of Directors as an independent director, effective immediately. Dr. Glimcher is currently a Professor of Medicine at Harvard Medical School and the President and Chief Executive Officer of the Dana-Farber Cancer Institute.
Dr. Glimcher’s appointment expands the Board to 11 directors, nine of whom are independent. She will be a member of the Board’s Compensation Committee.
“We are excited to have Laurie join the ADI Board as we continue to invest and develop innovative healthcare solutions for our customers,” said Ray Stata, ADI Chairman of the Board. “Laurie is a distinguished immunologist with extensive experience working in both private and public settings to advance research, medical education and health policy. In addition, Laurie is a pioneering mentor and strong advocate promoting women’s role in science. The insights she has gained over her medical career will be of great benefit to ADI as we aim to accelerate the growth of our healthcare business.”
Dr. Glimcher speaks nationally and internationally on cancer, immunology, skeletal biology, and translational medicine, and has contributed more than 350 scholarly articles and papers to the medical literature. She also currently serves on the Board of Directors at GlaxoSmithKline Pharmaceutical Corporation.
In addition to a number of senior leadership roles held at both Harvard Medical School and Harvard School of Public Health from 1982 to present, she has also served as the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University. She is a member of the Board of Trustees at the Dana-Farber Cancer Institute and a member of the US National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences and the American Philosophical Society. She previously served on the Board of Directors of Bristol-Myers Squibb Pharmaceutical Corporation and Waters Corporation.
She is also the recipient of many awards and honors. In 2018, she received the American Association of Immunologists Lifetime Achievement Award; the Indiana University School of Medicine's Steven C. Beering Award for outstanding research contributions to advancement of biomedical or clinical science; and the L'Oréal-UNESCO Award for Women in Science. She has also received the 2017 George M. Kober Medal and the 2017 Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges (AAMC).
Dr. Glimcher is a magna cum laude graduate of Radcliffe College, and holds an MD degree cum laude from Harvard Medical School.
Share on:
Testimonial
"In a year when every marketing dollar mattered, I chose to keep I-Connect007 in our 2025 plan. Their commitment to high-quality, insightful content aligns with Koh Young’s values and helps readers navigate a changing industry. "
Brent Fischthal - Koh YoungSuggested Items
Creative Materials to Showcase Innovative Functional Inks for Medical Devices at COMPAMED 2025
10/09/2025 | Creative Materials, Inc.Creative Materials, a leading manufacturer of high-performance functional inks and coatings, is pleased to announce its participation in COMPAMED 2025, taking place November 17–20 in Düsseldorf, Germany.
Service Robots See Global Growth Boom
10/07/2025 | IFRThe total number of service robots sold for professional use reached almost 200,000 units in 2024, marking a 9% increase. Staff shortages are a key driver for companies to use robots designed for trained professionals.
Alpha Insights, Performance by Design: The Future of PCB Manufacturing in the Midwest
10/07/2025 | Team Alpha -- Column: Alpha Insights: Performance by DesignFor years, Midwest PCB manufacturing was often viewed as a low-cost, high-volume business—good for standard builds but not for the high-reliability programs that demand tight process control. Defense primes and medical OEMs frequently turned to coastal or overseas suppliers for advanced work.
Global Wearable Medical Devices Market Predicted to Reach $185 Billion by 2032
10/01/2025 | Globe NewswireThe global wearable medical devices market is expected to increase from USD 43 billion in 2024 to USD 185 billion by 2032, reflecting strong and sustained growth.
NEOTech Celebrates Sixth Mexico Technology Award Win for Outstanding EMS Services Over $100M
09/19/2025 | NEOTechNEOTech, a leading provider of electronic manufacturing services (EMS), design engineering, and supply chain solutions in the high-tech industrial, medical device, and aerospace/defense markets, is proud to announce that it has once again earned the prestigious Mexico Technology Award in the category of EMS Services > $100 Million.